Neuronetics (STIM) Stock: Buy, Sell, or Hold?
STIM - Neuronetics, Inc. Common Stock
$2.88
0.16 (5.88%)
â˛
5d:
-2.04%
30d:
+28.0%
90d:
+123.26%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When STIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: STIM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: STIM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: STIM is currently trading at $2.88, which is considered slightly high relative to its 30-day fair value range of $2.20 to $3.15.
Technical Outlook: Technically, STIM is in a strong uptrend. Immediate support is located at $2.67, while resistance sits at $3.04. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.00 (+108.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STIM is in a strong uptrend. Immediate support is located at $2.67, while resistance sits at $3.04. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.00 (+108.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.20 -
$3.15
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.9%)
- BULLISH: Trading 108.3% below Wall St target ($6.00)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.20 -
$3.15
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.67
Resistance Level
$3.04
Current Trend
Strong Uptrend
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.47
Wall Street Target
$6.00
(+108.3%)
Revenue Growth (YoY)
9.1%
Profit Margin
-19.6%
Share & Embed Analysis
Last updated: September 07, 2026 12:38 AM ET
Data refreshes hourly during market hours. Next update: 1:38 AM
Data refreshes hourly during market hours. Next update: 1:38 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STIM showing a specific setup today?
Insider Activity (6 Months)
5
Buys
3
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jorey Chernett
BUY
100000 shares
2026-04-20
Jorey Chernett
BUY
169472 shares
2026-03-20
Jorey Chernett
BUY
450000 shares
2026-03-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 43 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 46 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 49 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 43 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
